Dual Energy CT vs Standard Triple Phase CT-A Randomised Control Trial

Renal Cell Carcinoma Clinical Trial

Official title:

Role of Split Bolus Dual Energy Single Acquisition CT in Evaluation of Urological Diseases of the Upper Urinary Tract.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02160600
• Other study ID #: IESC/T-457/29.11.2013
• Status: Completed
• Phase: N/A
• First received: June 7, 2014
• Last updated: April 26, 2017
• Start date: April 2014
• Est. completion date: December 2016

Study information

• Verified date: April 2017
• Source: All India Institute of Medical Sciences, New Delhi
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To compare SBDECT with standard Triple Phase Multi-Detector CT (TPMDCT) in renal mass evaluation in terms of appropriateness of treatment received after diagnosis. To determine SBDECT diagnostic accuracy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 124
• Est. completion date: December 2016
• Est. primary completion date: December 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients with suspected renal masses needing further evaluation with a contrast enhanced CT scan

• Patients who are referred for CT Urography

Exclusion Criteria:

• Patients not willing to participate in the study

• Age <18 yrs

• Pregnant females

• Patients with previous h/o serious allergic reactions or Contrast allergy

• Impaired renal function (estimated GFR<45mL/min/mm2)

• Sonographically proven benign renal mass needing no further evaluation

Related Conditions & MeSH terms

• AML
• Carcinoma
• Carcinoma, Renal Cell
• Carcinoma, Transitional Cell
• Renal Cell Carcinoma
• Renal Cysts
• Transitional Cell Carcinoma

Intervention

Other:
• Standard multiphase CT

• split bolus Dual energy CT

Locations

Country	Name	City	State
India	All India Institute of Medical Sciences	New Delhi	Delhi

Sponsors (1)

Lead Sponsor	Collaborator
All India Institute of Medical Sciences, New Delhi

Country where clinical trial is conducted

India, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Appropriateness of the treatment recieved		1 year